Updated EU GMP guide on drug quality, outsourced activities to apply from 2013
This article was originally published in SRA
Executive Summary
The European Commission has revised its good manufacturing practice guideline with updated chapters on pharmaceutical quality and outsourced activities, and an updated annex on manufacturing of biological active substances1. The revisions to the guideline will apply from January 2013.